Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Liver International : Official Journal of the International Association for the Study of the Liver|January 29, 2020
Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infectionJelte J Schaapman, Àlex Amoros, Johan J van der Reijden, et al.Cancer Letters|June 23, 2009
5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cellsPim J Koelink, Lukas J A C Hawinkels, Eliza Wiercinska, et al.Journal of Cellular and Molecular Medicine|June 28, 2019
Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating liversDanny van der Helm, Marieke C Barnhoorn, Eveline S M de Jonge-Muller, et al.Gastroenterology|June 14, 2021
Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile PatientsSam Nooij, Quinten R Ducarmon, Jeroen F J Laros, et al.Carcinogenesis|February 24, 2010
A new conditional Apc-mutant mouse model for colorectal cancerEls C Robanus-Maandag, Pim J Koelink, Cor Breukel, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 21, 2015
High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory deathA Claire den Dulk, Kerem Sebib Korkmaz, Bert-Jan F de Rooij, et al.Critical Care (London, England)|December 23, 2017
Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survivalAnnarein J C Kerbert, Hein W Verspaget, Àlex Amorós Navarro, et al.Plos One|March 17, 2022
How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantationBas Groenewegen, Emilie van Lingen, Rogier E Ooijevaar, et al.Inflammatory Bowel Diseases|January 24, 2007
Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's diseaseQiang Gao, Martin J W Meijer, Ulrike G Schlüter, et al.Inflammatory Bowel Diseases|January 9, 2007
Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel diseaseMartin J Meijer, Marij A C Mieremet-Ooms, Wim van Duijn, et al.Pageof 10